Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01900795 · ClinicalTrials.gov registry record · Phase 2
An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar Extraction
A Phase 2 study, sponsored by Purdue Pharma.
- Terminated
- Registry status
- Phase 2
- Development phase
- 114
- Enrollment target
NCT01900795: Clinical Trial Phase 2 study, sponsored by Purdue Pharma.
NCT01900795 is a Phase 2 study that was terminated before completion, run by Purdue Pharma. The registered enrollment target is 114 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (14% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01900795, a Phase 2 study, was terminated before completion, sponsored by Purdue Pharma.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 114 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the analgesic properties of an oral dose of V117957 4.5 mg aqueous suspension in the third molar extraction model
Primary Outcome
Time-weighted sum of pain relief scores 0 to 8 hours after dosing
Interventions
- DRUG Placebo
- DRUG Ibuprofen
- DRUG V117957
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2013-07 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
Why NCT01900795 stopped before completion
NCT01900795 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (14% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01900795 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01900795 about?
NCT01900795 is a clinical study titled "An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar Extraction". The primary objective of this study is to assess the analgesic properties of an oral dose of V117957 4.5 mg aqueous suspension in the third molar extraction model
What is the current status of trial NCT01900795?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 114 participants. The study started on 2013-07. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01900795?
The interventions under investigation include: Placebo (DRUG), Ibuprofen (DRUG), V117957 (DRUG).
Who is sponsoring clinical trial NCT01900795?
This trial is sponsored by Purdue Pharma, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01900795's enrollment target sits among peer trials
114 627th of 2000 higher than 1,370 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia